David Cunningham

Hancock Lumber Co., Inc. operates lumberyards and sells lumber and building materials. Its products include windows and doors, kitchens and bats, flooring, mouldings, and decking. The company was founded in 1848 and is headquartered at Casco, ME.

Kleinfeld Paper provides premier online wedding invitation and Christmas card services. The private company is based in Billerica.

William Arthur stationery, invitations, announcements and holiday cards are renowned worldwide for beautiful designs, substantial paper stock, rich embellishments and exceptional printing. For more than 60 years, William Arthur’s fine stationery products have helped people turn special moments and once in a lifetime occasions into lasting memories. At their home in West Kennebunk, Maine, their craftspeople keep the techniques and traditions of fine paper and printing alive, combining time-honored print methods with state of the art design and technology. Simply put, they are passionate about creating beautiful stationery. That passion is shared with their customers by providing exquisite products and extraordinary service.

The Yield Lab Manager LLC (Yield Lab Manager) is a venture capital firm founded in 2014 by Thad W Simons and Thomas Adamitis. The firm is headquartered in St. Louis, Missouri.

Covenant Animal Health Partners LLC was founded in 2018 and is based in an undisclosed location. The American company is dedicated to developing and registering "revenue-ready" animal health products to address critical market needs for both production and companion animals. Covenant's experienced team of animal health and technology professionals brings decades of expertise to rapidly evaluate, develop, and partner with animal health manufacturers and distributors. The company also collaborates with industry leaders to fund, develop, and accelerate external innovation initiatives.

Curtiss Healthcare, Inc. is an American healthcare company that provides a variety of JCAHO accredited care services. The private company's services include care at home, diabetes management, intravenous infusion, stroke recovery, and chronic obstructive pulmonary disease management. The company is focused on improving the lives of patients and their families, as evidenced by testimonials from caregivers and families.

Aptimmune Biologics, Inc. develops and markets a portfolio of revolutionary mucosal vaccines. It focuses on swine vaccines and the prevention of porcine reproductive and respiratory syndrome virus and influenza. The company was founded by Federico Zuckermann in 2010 and is headquartered in Champaign, IL.

Tonisity International Ltd. develops nutritional products for livestock industry. The company is headquartered in St. Joseph, MO.

Medical Network, Inc. operates an Internet site providing personal and family health care information. The company was founded in December 1994 and is headquartered in Cranbury, NJ.

Dalan Animal Health, Inc. is a company that focuses on providing animal health solutions to support a more sustainable future. The company is based in Athens, GA, at the University of Georgia's innovation hub. The company uses a platform vaccine technology that allows the maternal animal to pass immune modulators to the next generation larvae before they hatch. The company plans to develop vaccines for other honeybee diseases and underserved industries, such as shrimp, mealworms, and insects used in agriculture. The CEO of the company is Annette Kleiser.

Bimeda-MTC Animal Health, Inc. manufactures, markets and distributes animal health products and veterinary pharmaceuticals. The firm offers its products for cattle, sheep, goats, swine, horses, poultry, dogs and cats. It provides products under the categories of anti-inflammatory, anti-microbial, disinfectants/antiseptic, hormonal, intramammary, nutritional and sedative. The company was founded in 1964 and is headquartered in Cambridge, Canada.

Signet Healthcare Partners LLC (Signet Healthcare Partners) is a private equity/venture capital subsidiary of Sanders Morris Harris Group Private Equity founded in 1998. The firm is headquartered in New York.

Valera Pharmaceuticals, Inc. develops and commercializes products for the treatment of urology and endocrine conditions, diseases and disorders. The Company was founded in 1972 and is located in Cranbury, NJ.

Roberts Pharmaceutical Corp. provides pharmaceutical products. It offers medicines for cardiovascular, gynecology. The company is headquartered in Eatontown, NJ.

Oceana Therapeutics, Inc. manufactures pharmaceuticals and medical devices. It develops and commercializes therapeutics with a focus on colorectal, gastroenterology, and urological diseases. The firm provides Deflux that is used for the treatment of Vesicoureteral reflux, urological conditions and Solesta which is used for the treatment of fecal incontinence. The company was founded in 2008 and is headquartered in Edison, NJ.

Icon Bioscience, Inc. develops and markets ophthalmic pharmaceuticals. It develops specialty pharmaceuticals targeting ophthalmic indications including macular edema, glaucoma, age-related macular degeneration and cataract surgery. The firm's pipeline includes IBI-10090, IBI-20089, IBI-60089, and IBI-80090. The company was founded by Vernon G. Wong and is headquartered in Newark, CA.

Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA.

Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA.

Pharma Two B Ltd. operates as a biopharmaceutical company which focuses on developing treatments for Parkinson’s disease. The firm focuses on Fixed-Dose-combinations of two or more drugs with synergistic effects, providing clinical value and regulatory pathways. The company was founded by Ehud Marom and Nurit Livnah in December 2007 and is headquartered in Rehovot, Israel.

Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company based in Medfield, MA. Aramis Biosciences is committed to developing disease-modifying therapy for ocular surface disease, starting with dry eye disease. The company's lead product candidate, A197, is a novel, first-in-class, topical immunomodulatory agent currently in a phase II clinical proof of concept for the treatment of dry eye disease. The company was founded in 2018 by Sunil Chauhan, Reza Dana, and the CEO is David S. Tierney. Aramis Biosciences was founded by leading experts in the fields of corneal disorders, ocular inflammation, and immunology from the Schepens Eye Research Institute of Mass Eye and Ear and the Department of Ophthalmology at Harvard Medical School, with support from Safar Partners, Dompé Farmaceutici S.p.A., and a leader in ophthalmic pharmaceuticals.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.